Impact of Baseline Anti-ABO Antibody Titer on Biliary Complications in ABO-Incompatible Living-Donor Liver Transplantation

Although advancements in desensitization protocols have led to increased ABO-incompatible (ABOi) living-donor liver transplantation (LDLT), a higher biliary complication rate remains a problem. This study evaluated the effect of baseline anti-ABO antibody titers before desensitization on biliary com...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2024-08, Vol.13 (16), p.4789
Main Authors: Yu, Se-Hyeon, Jo, Hye-Sung, Yu, Young-Dong, Park, Pyoung-Jae, Han, Hyung-Joon, Kim, Sang-Jin, Kamarulzaman, Syahrul Hadi, Kim, Dong-Sik
Format: Article
Language:English
Subjects:
Antibodies
Bile ducts
Cholangitis
Endoscopy
Immunology
Laparoscopy
Liver diseases
Liver transplants
Mortality
Postoperative period
Radiation
Risk factors
Surgery
Tomography
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although advancements in desensitization protocols have led to increased ABO-incompatible (ABOi) living-donor liver transplantation (LDLT), a higher biliary complication rate remains a problem. This study evaluated the effect of baseline anti-ABO antibody titers before desensitization on biliary complications after ABOi LDLT. The study cohort comprised 116 patients in the ABO-compatible group (ABOc), 29 in the ABOi with the low titer (
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm13164789